{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:30:06Z","timestamp":1790094606337,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.vaccine.2011.06.062","type":"journal-article","created":{"date-parts":[[2011,7,16]],"date-time":"2011-07-16T22:09:43Z","timestamp":1310854183000},"page":"5925-5931","source":"Crossref","is-referenced-by-count":92,"title":["Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO\u00ae) induced neutralizing antibody titers"],"prefix":"10.1016","volume":"29","author":[{"given":"Yvonne","family":"Van Gessel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph S.","family":"Klade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Putnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Formica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somporn","family":"Krasaesub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Spruth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Cena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchalee","family":"Tungtaeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montip","family":"Gettayacamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh","family":"Dewasthaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.06.062_bib0005","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3201\/eid1702.100815","article-title":"Introduction of Japanese encephalitis virus genotype I, India","volume":"17","author":"Fulmali","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0010","first-page":"276","article-title":"Japanese encephalitis in two children\u2014United States 2010","volume":"60","author":"Centers for disease control and prevention (CDC)","year":"2011","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0015","series-title":"Vaccine","first-page":"919","article-title":"Japanese encephalitis vaccines","author":"Halstead","year":"2004"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0020","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/S0264-410X(00)00111-0","article-title":"Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States","volume":"18","author":"Takahashi","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0025","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/651271","article-title":"Japanese encephalitis: new options for active immunization","volume":"50","author":"Halstead","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0030","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1016\/S0264-410X(01)00208-0","article-title":"A purified Japanese encephalitis virus vaccine made in Vero cells","volume":"19","author":"Srivastava","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0035","unstructured":"Ixiaro (SPC) European Medicinal Agency, <http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000963\/WC500037287.pdf> [website accessed 03.05.11]."},{"key":"10.1016\/j.vaccine.2011.06.062_bib0040","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/S0140-6736(07)61780-2","article-title":"Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial","volume":"370","author":"Tauber","year":"2007","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2011.06.062_bib0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0264-410X(00)00038-4","article-title":"Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines","volume":"18","author":"Markoff","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0050","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4269\/ajtmh.1986.35.1045","article-title":"Isolation of Japanese encephalitis virus from clinical specimens using a continuous mosquito cell line","volume":"35","author":"Leake","year":"1986","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"10.1016\/j.vaccine.2011.06.062_bib0060","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/biomet\/64.1.156","article-title":"On distribution-free tests for equality of survival distributions","volume":"64","author":"Tarone","year":"1977","journal-title":"Biometrika"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0065","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0070","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1086\/522428","article-title":"A framework for assessing immunological correlates of protection in vaccine trials","volume":"196","author":"Qin","year":"2007","journal-title":"JID"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Correlates of vaccine-induced immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0080","doi-asserted-by":"crossref","first-page":"7851","DOI":"10.1128\/JVI.71.10.7851-7856.1997","article-title":"Immunologic correlates of protection against rotavirus challenge after intramuscular immunization of mice","volume":"71","author":"Coffin","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0085","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1016\/S0264-410X(03)00382-7","article-title":"Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice","volume":"21","author":"Konishi","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0090","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1086\/381768","article-title":"Helper 1 function of nonstructural protein 3\u2014specific T cells in Japanese patients with encephalitis with neurological sequelae","volume":"189","author":"Kumar","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1442-200X.1988.tb02516.x","article-title":"Japanese encephalitis vaccine","volume":"30","author":"Oya","year":"1988","journal-title":"Acta Paediatr Jpn"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0100","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/0264-410X(95)00099-M","article-title":"Antigenic analysis of Japanese encephalitis viruses in Asia using monoclonal antibodies","volume":"13","author":"Hasegawa","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0105","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1016\/j.vaccine.2004.03.027","article-title":"Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVaxTM-JE experimental vaccine","volume":"22","author":"Beasley","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0110","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0115","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.virol.2009.10.023","article-title":"Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy","volume":"396","author":"Simmons","year":"2010","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2011.06.062_bib0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.biologicals.2007.07.002","article-title":"Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines\u2014report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies","volume":"36","author":"Ferguson","year":"2008","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0125","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0264-410X(92)90051-K","article-title":"Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: a comparison with isolates of the virus covering a wide geographic area","volume":"10","author":"Wills","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0130","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4269\/ajtmh.2001.65.242","article-title":"Phylogenetic analysis of Japanese encephalitis virus: envelope gene based analysis reveals a fifth genotype, geographic clustering, and multiple introductions of the virus into the Indian subcontinent","volume":"65","author":"Uchil","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0135","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0264-410X(00)00039-6","article-title":"Phylogenetic analysis suggests only on serotype of Japanese encephalitis virus","volume":"18","author":"Tsarev","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0140","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/JVI.77.5.3091-3098.2003","article-title":"Origin and evolution of Japanese encephalitis virus in Southeast Asia","volume":"77","author":"Solomon","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4269\/ajtmh.2003.69.151","article-title":"Short report: a major genotype of Japanese encephalitis virus currently circulating in Japan","volume":"69","author":"Ma","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2011.06.062_bib0150","doi-asserted-by":"crossref","first-page":"e16418","DOI":"10.1371\/journal.pone.0016418","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11009261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11009261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T10:03:13Z","timestamp":1592733793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11009261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":30,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0264410X11009261"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.06.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}